Bimekizumab Impact on Patient-Reported Outcomes in Patients With Moderate to Severe Hidradenitis Suppurativa: Pooled Week 48 Results from BE HEARD I&II. J of Skin 2024, 8 (6), s476. https://doi.org/10.25251/skin.8.supp.476.